TX1-85-1

CAS No. 1603845-32-4

TX1-85-1( —— )

Catalog No. M23702 CAS No. 1603845-32-4

TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 123 In Stock
10MG 217 In Stock
25MG 370 In Stock
50MG 532 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TX1-85-1
  • Note
    Research use only, not for human use.
  • Brief Description
    TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling.
  • Description
    TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling. TX1-85-1 is an irreversible Her3 inhibitor (IC50: 23 nM). TX1-85-1 is also the first selective Her3 ligand, which forms a covalent bond with Cys721 located in the ATP-binding site of Her3.
  • In Vitro
    TX1-85-1 possesses an anti-proliferation EC50s of 9.9, 11.5, and 16.9 μM for Ovcar8, HCC827 GR6, and PC9 GR4 cells, respectively.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ErbB3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1603845-32-4
  • Formula Weight
    580.68
  • Molecular Formula
    C32H36N8O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:3.85 mg/mL (6.63 mM; Need ultrasonic)
  • SMILES
    CC(N1CCN(C2CCC(N3N=C(C4=CC(NC(C=C)=O)=C(OC5=CC=CC=C5)C=C4)C6=C3N=CN=C6N)CC2)CC1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xie T, et al. Pharmacological targeting of the pseudokinase Her3. Nat Chem Biol. 2014 Dec;10(12):1006-12.
molnova catalog
related products
  • PF-06747775

    A potent, selective, irreversible EGFR mutants with IC50 of 12, 3, 4 and 5 nM for EGFR L858R-T790M, Del-T790M, L858R, and EGFR Del, respectively.

  • Erlotinib

    A potent, selective inhibitor of EGFR with IC50 of 2 nM; reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM.

  • BMS-690514

    A potent pan HER/VEGFR inhibitor with IC50 of 5/20/60/50 nM for EGFR/HER2/ERBB4/VEGFR2 respectively.